GastroAGI

by GastroAGI  · Based in India → — AI Chat for Gastroenterology
Colorectal Surgery Gastroenterology General Surgery
Website
Claim this tool
Is this the maker? Claim the company →

Contact for details

Overview

GastroAGI is an AI-powered platform designed for the field of gastroenterology and hepatology, developed by YRaM Biosolutions. [1, 2] It aims to provide specialized intelligence for various users within the GI ecosystem. [2]

The tool is intended for a broad audience including:

  • Practicing Gastroenterologists, Hepatologists, GI Surgeons, Physicians, and Endoscopists: For clinical decision support and evidence-based insights. [2, 4, 8]
  • Medical Students (MBBS, MD, USMLE), Postgraduate Trainees, and Exam Aspirants: For structured learning, exam preparation, and understanding foundational concepts in gastroenterology and hepatology. [1, 3, 6]
  • Researchers: To explore studies, analyze data, and stay updated on new developments. [1, 3, 7]
  • Patients: To understand digestive health conditions with simplified explanations. [2, 4, 5]

GastroAGI integrates into clinical and practice workflows by offering different modes tailored to user needs: [2, 9]

  • Clinician Mode: Provides updated, guideline-based, and clinically actionable insights, drawing from major international guidelines and review articles. [4] This mode functions to support clinical decisions with evidence-based information. [4]
  • Student Mode: Delivers structured, concept-driven learning, combining textbook foundations, clinical reasoning, and simplified explanations. [4]
  • Researcher Mode: Facilitates exploration of research, data connections, and staying current with studies, guidelines, and conference updates. [4, 7]
  • Patient Mode: Offers plain-language explanations of symptoms, tests, and reports, focusing on common causes and warning signs, designed to be a calm and empathetic assistant. [4, 5]

Notable capabilities include providing evidence-based clinical decision support, advanced learning resources, and accessible GI insights. [4] It organizes information across various GI and hepatology domains, such as liver disorders, inflammatory bowel disease (IBD), stomach disorders, pancreatitis, and upper GI tract disorders. [2, 4] The platform also aims to simplify complex GI topics and assist with communication. [2, 4]

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered chat platform
  • Evidence-based insights
  • Clinical decision support
  • Multiple user modes (Student, Clinician, Researcher, Patient)
  • Access to updated medical literature, guidelines, and conference insights
  • Structured learning for students
  • Guideline-based insights for clinicians
  • Research intelligence for academics
  • Simplified explanations for patients
  • User authentication & security
  • Conversation management & history
  • Customization & user preferences

Use Cases

  • Supporting clinical decisions with reliable, evidence-based insights for practicing gastroenterologists, hepatologists, GI surgeons, physicians, and endoscopists.
  • Providing structured, concept-driven learning in Gastroenterology and Hepatology for MBBS students, postgraduate trainees, and exam aspirants.
  • Enabling researchers to explore deeper knowledge, map evidence, connect mechanisms to outcomes, and track the latest scientific advancements.
  • Offering patients simple, easy-to-follow explanations of their conditions, symptoms, tests, and medications to reduce confusion and guide safe next steps.
  • Staying updated on the latest GI research, guidelines, and conference updates.
  • Exploring complex GI topics with clarity and turning medical documents into insights.

What Physicians Need to Know

Evidence Base (guidelines, literature scope)
GastroAGI's Clinician Mode provides evidence-based insights powered by major international guidelines and landmark review articles. It organizes information across a broad spectrum of digestive health domains including hepatology, inflammatory bowel disease, GI oncology, endoscopy, liver transplantation, cirrhosis, hepatocellular carcinoma, upper gastrointestinal disease, pancreaticobiliary disorders, GI surgery, and basic sciences. The platform also incorporates continuously updated topic environments that reflect evolving conference intelligence and subspecialty literature.
Clinical Validation Studies
GastroAGI integrates validated models, such as those used for real-time prediction of therapeutic plasma exchange (TPE) response in pediatric acute liver failure, to assist liver transplant decision-making. Machine learning models within GastroAGI have accurately predicted response to TPE, allowing early identification of responders and non-responders. The platform was internally stress-tested across Student, Clinician, and Patient modes, with Clinician Mode designed for clinical reasoning and decision support.
Differential Diagnosis Support
GastroAGI's Clinician Mode is specifically designed to assist with clinical reasoning, including prioritizing risks, building differential diagnoses, identifying urgent conditions, and choosing appropriate next steps. It helps structure questions related to complex GI scenarios, such as differentiating autoimmune pancreatitis from pancreatic cancer or risk-stratifying pancreatic cysts. The platform aims to organize reasoning in a structured and safe way, prioritizing malignancy when alarm features are present and avoiding inappropriate interventions.
Guideline Update Frequency
GastroAGI provides updated, guideline-based, and clinically actionable insights. The platform includes continuously updated topic environments that reflect rapidly changing GI guidelines, society recommendations, journal articles, conference abstracts, and therapeutic developments.
Clinical Workflow Integration
GastroAGI is designed to be a structured intelligence layer for GI-focused learning, clinical context, and patient-friendly communication, rather than a replacement for physicians. It aims to fit within existing clinical workflows, with an emphasis on being integrated into real workflows. The platform is HIPAA-ready and aims to help clinicians, trainees, and patients navigate complex GI information with more clarity, speed, and context.
Decision Audit Trail
The importance of audit trails for accountability in AI systems, particularly in regulated industries like healthcare, is highlighted in general discussions about AI. These trails should record lifecycle events and decisions, linking technical provenance with governance records to reconstruct what changed, when, and who authorized it. While GastroAGI is designed for human oversight and aims for responsible implementation, specific details about its internal decision audit trail functionality are not explicitly provided.
Physician Tip

Leverage GastroAGI's Clinician Mode for evidence-backed insights on complex GI cases, differential diagnoses, and next-step management. Utilize its role-adaptive design to quickly access information tailored to your specific needs, whether for patient care, academic presentations, or staying current with the latest guidelines and research. Remember that GastroAGI is an assistive tool, designed to augment your clinical judgment, not replace it. Always consider the clinical context and your patient's individual needs when making decisions.

GastroAGI is built as a HIPAA-ready, specialized AI platform for gastroenterology. While direct EHR integration details are not extensively described, the broader discussion around medical AI emphasizes that GI intelligence systems should fit within existing clinical environments (e.g., EHR, inbox, documentation) rather than creating disconnected workflows, often leveraging modern interoperability standards like HL7 FHIR, CDS Hooks, and SMART on FHIR.

Details

Category Clinical Decision Support & Reference, Medical Education & Training, Patient Engagement & Education
Pricing Contact for details
  • GastroAGI offers different modes (Student, Clinician, Researcher, Patient), suggesting potentially varied pricing or access tiers, but specific pricing information is not publicly available on the website
DeploymentCloud-based
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status Unknown AI-estimated

GastroAGI's website mentions that regulatory scope matters and references FDA's 2026 guidance on clinical decision support software, clarifying that some CDS functions may fall outside device regulation, while others remain subject to FDA's digital-health framework depending on intended use. The platform itself does not claim FDA clearance, and it is important to note that AI systems in endoscopy for real-time polyp detection, while holding a CE mark in Europe, do not yet have United States FDA approval.
Integrations
EHR Not specified
Specialties Colorectal Surgery, Gastroenterology, General Surgery

What the Web Says

GastroAGI is an AI-powered platform developed by YRaM Biosolutions, an Indian AI startup, specifically designed for gastroenterology. It offers educational resources, interactive learning modules, and real-time access to medical literature for students and researchers. The platform also provides clinical decision support for practicing gastroenterologists, hepatologists, GI surgeons, physicians, and endoscopists, with different modes tailored for students, clinicians, and patients.

Overall: Positive

Strengths

  • Specialized for gastroenterology, offering in-depth and relevant information.
  • Features different modes (Student, Clinician, Patient) to adapt to user needs and provide tailored responses.
  • Provides evidence-based and guideline-informed answers for clinical decision support.
  • Offers educational resources, practice questions, and exam preparation tools for students.
  • Aids researchers in exploring studies, data analysis, and mapping evidence.
  • Designed with HIPAA-ready architecture for secure handling of health information.

Limitations

  • No specific cons were found in the provided search results regarding GastroAGI. However, general challenges with AI adoption in healthcare include data quality, interpretability, ethical concerns, algorithmic biases, and data privacy issues.
  • The information available is largely promotional or descriptive from the company and a single review article, lacking independent user reviews from platforms like Reddit, G2, or Capterra specifically for GastroAGI.

Based on reviews from: PMC (Gastroenterology in the age of artificial intelligence: Bridging technology and clinical practice), GastroAGI.com (AI For Gastroenterology | GastroAGI for GI Learning, Clinical Reasoning, and Patient Communication), GastroAGI.com (GastroAGI | AI Chat for Gastroenterology), YRaM Biosolutions LLP (GastroAGI u2013 AI Assistant for Gastroenterology Students and Doctors), GastroAGI.com (GastroAGI for Clinicians | AI Clinical Decision Support for Gastroenterology), GastroAGI.com (GastroAGI for Medical Students | AI Gastroenterology Study Companion), Reddit (u/GastroAGI), GastroAGI.com (GastroAGI for Researchers | AI Research Intelligence for Gastroenterology), GastroAGI.com (Gastroenterology Blogs)

Last updated: 2026-10-07

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate GastroAGI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

GastroAGI
AI-Assisted Colonoscopy in 2026: What the JAMA Autonomous-AI Debate Means for Endoscopists - GastroAGI
This article discusses the debate around autonomous AI versus human-in-the-loop AI in medicine, specifically in the context of AI-assisted colonoscopy, and highlights the potential for AI-induced deskilling in endoscopists. It references a 2026 JAMA Perspective challenging the augmented-intelligence consensus.
2026-09
GastroAGI
Serrated Polyposis Syndrome: What the 2026 US Multi-Society Task Force Consensus Means for CRC Prevention - GastroAGI
This article summarizes the 2026 US Multi-Society Task Force consensus statement on serrated polyposis syndrome, emphasizing its underrecognition as a common colorectal cancer risk condition and the need for systematic endoscopic documentation and management. The statement was jointly published in Gastrointestinal Endoscopy, Gastroenterology, and The American Journal of Gastroenterology.
2026-10
GastroAGI
Preventive Care in Cirrhosis: What the 2026 ACG Guideline Means for Hepatology Practice - GastroAGI
This article discusses the 2026 American College of Gastroenterology (ACG) guideline on preventive care for patients with cirrhosis, focusing on systematic interventions before or after decompensating events. The guideline was published in The American Journal of Gastroenterology.
2026-10
PMC (PubMed Central)
Gastroenterology in the age of artificial intelligence: Bridging technology and clinical practice - PMC
This peer-reviewed article highlights the transformative role of AI, deep learning, and radiomics in gastroenterology and hepatology, enhancing diagnostic accuracy, personalized therapy, and drug discovery. It specifically mentions GastroAGI as an AI-powered platform for learning in gastroenterology, offering educational resources and tailored recommendations.
2025-09
PMC (PubMed Central)
The role of artificial intelligence in gastroenterology: current perspectives and future directionsu2014narrative review - PMC
This narrative review explores the significant potential of AI to improve patient care in gastroenterology, emphasizing future advancements requiring collaboration among AI developers, clinicians, and patients. It covers AI-assisted computer vision applications in preventing colorectal cancer and improving polyp detection rates.
2026-01
Healio
AGA launches AI-powered virtual assistant for gastroenterology and hepatology care
The American Gastroenterological Association (AGA) launched 'Nigel,' an AI-powered virtual assistant built on AGA's peer-reviewed clinical guidelines to provide clinicians with fast, evidence-based answers for digestive disease care. Nigel aims to reduce clinician cognitive burden and keep them updated with evolving guidelines.
2026-07
GastroAGI
AI For Gastroenterology | GastroAGI for GI Learning, Clinical Reasoning, and Patient Communication
This article explains the need for specialized AI in gastroenterology due to the field's knowledge density and the overwhelming pace of new information. It introduces GastroAGI as a HIPAA-ready AI platform designed for GI-focused learning, clinical context, and patient-friendly communication, with modes for students, clinicians, and patients.
2026-06
HCPLive
Q4 2025 Recap: Gastroenterology News and Updates - HCPLive
This recap of Q4 2025 gastroenterology news highlights major regulatory decisions and updated clinical guidance, including FDA approvals for inflammatory bowel disease treatments and the AGA's updated guideline for Crohn's disease emphasizing early use of high-efficacy therapies.
2026-01

Videos

Product demos, reviews, and walkthroughs for GastroAGI.

View all on YouTube

Frequently Asked Questions

GastroAGI is an AI-powered clinical decision support tool designed to assist gastroenterologists. It integrates by analyzing patient data from EHRs to provide real-time insights and recommendations, aiming to streamline diagnostic and treatment pathways.
GastroAGI is developed to align with established medical guidelines and best practices in gastroenterology. It aims to reduce diagnostic errors by offering evidence-based suggestions and flagging potential discrepancies in patient data, thereby supporting more accurate clinical judgments.
Alternatives to GastroAGI include other AI-driven platforms and traditional manual review of guidelines and literature. GastroAGI differentiates itself through its specialized focus on gastroenterology and its ability to process complex patient data rapidly, aiming for superior efficacy in specific use cases.
The pricing model for GastroAGI typically involves tiered subscriptions, with options tailored for individual practitioners, small clinics, and large hospital systems. Specific pricing details and available tiers can be obtained by contacting the vendor directly.
GastroAGI's limitations include its reliance on the quality and completeness of available patient data; incomplete or inaccurate data can affect its recommendations. While it is continuously learning, its ability to provide definitive guidance on extremely rare or highly complex, atypical gastrointestinal conditions may also be limited.
GastroAGI is designed with robust data privacy and security measures, adhering to relevant healthcare regulations like HIPAA. It employs encryption, access controls, and anonymization techniques to protect sensitive patient health information.
Comprehensive training programs are typically provided for physicians to effectively utilize GastroAGI, including initial onboarding, user manuals, and ongoing technical support. Regular updates and educational resources are also offered to ensure users can leverage new features and improvements.

Related Tools

DeepMind (Google)
Google DeepMind
Clinical Decision Support & Reference
AlphaFold is an AI system developed by DeepMind (Google) that accurately predicts protein structures and their interactions, significantly accelerating biological and medical research.
Free for non-commercial use
Tempus AI
Tempus AI
Clinical Decision Support & Reference
Tempus ECG-AI Platform uses artificial intelligence to analyze electrocardiogram data, offering advanced insights for cardiovascular diagnosis and management.
Cortex
Cortex
Clinical Decision Support & Reference
Cortex Workspace is a secure, HIPAA-compliant AI platform designed to streamline healthcare workflows and enhance decision-making for physicians.
Starts free, then $29/month for individual plan (save 10% annually). other plans: enthusiast ($99/month), business ($349/month), enterprise (contact sales).
SureMediks ProView
SureMediks (Rasimo Systems, LLC)
Clinical Decision Support & Reference
SureMediks is an AI-powered clinical decision support and metabolic health platform that automates care workflows for specialists, providing AI-generated patient summaries, automated chart review, and real-time biometric alerts.
SOAP Health
SOAP Health
Clinical Decision Support & Reference
SOAP Health is a Florida-based startup transforming patient intake with AI-powered diagnosis, offering a comprehensive solution that improves diagnosis accuracy and empowers patients and physicians.
Oxipit ChestLink
Oxipit (part of Sectra group)
Clinical Decision Support & Reference
Oxipit ChestLink is the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity. It automates the reporting of normal chest X-rays, reducing radiologist workload and improving efficiency.

See all Clinical Decision Support & Reference tools →

Suggest an Edit → | Last Verified: 2026-07-07 | First Added: 2026-07-07
AI Tool Finder
AI-powered search. Results may not be comprehensive.